Karen L Baldini, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 190 Main St, Ogdensburg, NJ 07439 Phone: 973-229-5067 |
News Archive
A team of immunology experts from research organizations in Belgium and the UK has come together to apply their pioneering research methods to put individuals' COVID-19 responses under the microscope.
Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication for Bayer's Kogenate® FS antihemophilic factor VIII (recombinant), for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.
There is enough scientific evidence now to show that dogs can be powerful motivators to get people moving. Dog owners are more likely to take regular walks and new research has shown that dog walkers are more active overall than people who don't have dogs. One of the studies showed that older people are more likely to take regular walks if the walking companion is canine rather than human.
Researchers from the U.K. suggest that using organs from donors after circulatory death (DCD) who also suffered a previous cardiac arrest out of the hospital environment could expand the pool of available livers for transplant.
Portola Pharmaceuticals and Merck today announced the results of EXPLORE-Xa, a Phase 2 exploratory, dose finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. Results showed that a once-daily dose of oral betrixaban, given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.
› Verified 6 days ago